• Merck KGaA Selects PRA’s Remote Patient Monitoring Platform contractpharma
    April 09, 2021
    Merck KGaA, Darmstadt, Germany, known in the U.S. as EMD Serono, has selected PRA Health Sciences’ remote patient monitoring platform to work in combination with its human growth hormone (HGH) treatment system.
PharmaSources Customer Service